About Jocelyn Lee

This author has not yet filled in any details.
So far Jocelyn Lee has created 5 blog entries.

Dr. Jennifer Stinson Receives Gairdner Momentum Award for Transforming Paediatric Pain Care

By |2025-04-14T18:52:23+00:00April 14th, 2025|

AWARD ANNOUNCEMENT SickKids’ Dr. Jennifer Stinson Receives Gairdner Momentum Award for Transforming Paediatric Pain Care We’re thrilled to celebrate Dr. Jennifer Stinson, Nurse Practitioner, Senior Scientist, and long-time innovator at SickKids, as the recipient of the 2025 Peter Gilgan Canada Gairdner Momentum Award. Dr. Stinson is the first nurse [...]

SickKids’ Dr. Jayne Danska named UHN Inventor of the Year

By |2025-03-27T19:19:00+00:00March 27th, 2025|

AWARD ANNOUNCEMENT SickKids’ Dr. Jayne Danska named UHN Inventor of the Year for innovation in cancer immunotherapy The Industry Partnerships & Commercialization (IP&C) team is proud to congratulate Dr. Jayne Danska of The Hospital for Sick Children (SickKids), along with Drs. Jean Wang and John Dick of University Health Network [...]

SickKids Researcher Receives Commercialization Grant for Development of COPD Treatment

By |2025-03-27T14:49:57+00:00September 27th, 2024|

FUNDING ANNOUNCEMENT SickKids Researcher Receives Commercialization Grant for Development of COPD Treatment Dr. Christine Bear, Senior Scientist and Co-Director of the Cystic Fibrosis Centre at The Hospital for Sick Children (SickKids) and Professor at The University of Toronto, has been awarded $325,125 to support the commercialization of a novel treatment for [...]

Radiant Biotherapeutics Secures $35 Million to Advance Multabody™ Therapeutics

By |2025-03-27T14:51:37+00:00September 11th, 2024|

FUNDING ANNOUNCEMENT Radiant Biotherapeutics Secures $35 Million to Advance Multabody™ Therapeutics Industry Partnerships & Commercialization (IP&C) is excited to share that Radiant Biotherapeutics has closed a $35 million USD series A financing co-led by the Bill & Melinda Gates Foundation and Amplitude Ventures. Radiant Biotherapeutics is [...]

Go to Top